Beaver Sandra 4
Research Summary
AI-generated summary
Tandem Diabetes (TNDM) Director Sandra Beaver Receives Award
What Happened
Sandra Beaver, a director of Tandem Diabetes Care, Inc. (TNDM), received a grant of 5,110 restricted stock units (RSUs) on May 20, 2026. The award shows $0.00 cash paid (a grant/derivative award). The RSUs represent contingent rights to receive one share (or cash in lieu) at the issuer's discretion when they vest.
Key Details
- Transaction type: Award/Grant (derivative RSUs) recorded 2026-05-20; Form 4 filed 2026-05-22 (timely).
- Quantity: 5,110 RSUs; reported acquisition price $0.00 (grant).
- Vesting: These RSUs were granted May 20, 2026 and vest on the one-year anniversary (May 20, 2027), subject to the 2023 Long-Term Incentive Plan (footnotes F1–F2).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Remarks: Filing includes Exhibit 24 (Power of Attorney).
Context
RSU grants are a common form of compensation for directors and executives and do not involve an immediate purchase or sale of stock. Because these are time-vesting awards, they do not necessarily signal near-term buying or selling intent; they simply represent future potential equity compensation subject to vesting and plan terms.
Loading document...